This study’s purpose was to investigate mortality among individuals with autism spectrum disorders (ASD) ascertained during a 1980s statewide autism prevalence study (n = 305) in relation to controls. Twenty-nine of these individuals (9.5 %) died by the time of follow up, representing a hazard rate ratio of 9.9 (95 % CI 5.7–17.2) in relation to population controls. Death certificates identified respiratory, cardiac, and epileptic events as the most common causes of death. The elevated mortality risk associated with ASD in the study cohort appeared related to the presence of comorbid medical conditions and intellectual disability rather than ASD itself suggesting the importance of coordinated medical care for this high risk sub-population of individuals with ASD.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Baird, P. A., & Sadovnick, A. D. (1990). Underlying causes of death in Down syndrome: Accuracy of British Columbia death certificate data. Canadian Journal of Public Health, 81(6), 456–461.
Bilder, D., Pinborough-Zimmerman, J., Miller, J., & McMahon, W. (2009). Prenatal, perinatal, and neonatal factors associated with autism spectrum disorders. Pediatrics, 123(5), 1293–1300.
CIA World Factbook. (2011a). Sweden death rate. Retrieved from http://www.cia.gov.
CIA World Factbook. (2011b). United States death rate. Retrieved from http://www.cia.gov.
Centers for Disease Control and Prevention. (2009). Prevalence of autism spectrum disorders—Autism and developmental disabilities monitoring network, United States, 2006. Morbidity and Mortality Weekly Report, 58(10), 1–20.
Danielsson, S., Gillberg, I. C., Billstedt, E., Gillberg, C., & Olsson, I. (2005). Epilepsy in young adults with autism: A prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia, 46(6), 918–923.
Depositario-Cabacar, D. F., & Zelleke, T. G. (2010). Treatment of epilepsy in children with developmental disabilities. Developmental Disabilities Research Reviews, 16(3), 239–247.
Doria-Rose, V. P., & Marcus, P. M. (2009). Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: An example from the Mayo Lung Project. Lung Cancer, 63(2), 295–300.
Farley, M. A., McMahon, W. M., Fombonne, E., Jenson, W. R., Miller, J., Gardner, M., et al. (2009). Twenty-year outcome for individuals with autism and average or near-average cognitive abilities. Autism, 2(2), 109–118.
Gillberg, C., Billstedt, E., Sundh, V., & Gillberg, I. C. (2010). Mortality in autism: A prospective longitudinal community-based study. Journal of Autism and Developmental Disorders, 40(3), 352–357.
Gillberg, C., & Coleman, M. (1996). Autism and medical disorders: A review of the literature. Developmental Medicine and Child Neurology, 38, 191–202.
Isager, T., Mouridsen, S. E., & Rich, B. (1999). Mortality and causes of death in pervasive developmental disorders. Autism, 3, 7–16.
Kobayashi, R., Murata, T., & Yoshinaga, K. (1992). A follow-up study of 201 children with autism in Kyushu and Yamaguchi areas, Japan. Journal of Autism and Developmental Disorders, 22(3), 395–411.
Larsson, H. J., Eaton, W. W., Madsen, K. M., Vestergaard, M., Olesen, A. V., Agerbo, E., et al. (2006). Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. American Journal of Epidemiology, 161(10), 916–925.
Miller, J. S., Bilder, D., Farley, M., Coon, H., Pinborough-Zimmerman, J., Jenson, W., et al. (2012). Autism spectrum disorder reclassified: A second look at the 1980’s Utah/UCLA Autism Epidemiologic Study. Journal of Autism and Developmental Disorders. doi:10.1007/s10803-012-1566-0.
Mouridsen, S. E., & Brønnum-Hansen, H. (2008). Mortality and causes of death in autism spectrum disorders: An update. Autism, 12(4), 403–414.
Pellock, J. (2004). Understanding co-morbidities affecting children with epilepsy. Neurology, 62(supplement 2), S17–S23.
Pickett, J. A., Paculdo, D. R., Shavelle, R. M., & Strauss, D. J. (2006). 1998–2002 Update on “Causes of Death in Autism”. Journal of Autism and Developmental Disorders, 36, 287–288.
Pickett, J., Xiu, E., Tuchman, R., Dawson, G., & Lajonchere, C. (2011). Mortality in individuals with autism, with and without epilepsy. Journal of Child Neurology, 26(8), 932–939.
Pinborough-Zimmerman, J., Bakian, A., Fombonne, E., Bilder, D., Taylor, J., & McMahon, W. M. (2012). Changes in the administrative prevalence of autism spectrum disorders: Contribution of special education and health data from 2002–2008. Journal of Autism and Developmental Disorders, 42, 521–530.
Rice, C. E., Baio, J., Van Naarden Braun, K., Doernberg, N., Meaney, F. J., Kirby, R. S., et al. (2007). A public health collaboration for the surveillance of autism spectrum disorders. Paediatric and Perinatal Epidemiology, 21(2), 179–190.
Ritvo, E. R., Freeman, B. J., Pingree, C., Mason-Brothers, A., Jorde, L., Jenson, W. R., et al. (1989). The UCLA-University of Utah epidemiologic survey of autism: Prevalence. American Journal of Psychiatry, 146(2), 194–199.
Ritvo, E. R., Mason-Brothers, A., Freeman, B. J., Pingree, C., Jenson, W. R., McMahon, W. M., et al. (1990). The UCLA-University of Utah epidemiologic survey of autism: The etiologic role of rare diseases. American Journal of Psychiatry, 147(12), 1614–1621.
Shavelle, R. M., Strauss, D. J., & Pickett, J. (2001). Causes of death in autism. Journal of Autism and Developmental Disorders, 31, 569–576.
Symons, M. J., & Moore, D. T. (2002). Hazard rate ratio and prospective epidemiological studies. Journal of Clinical Epidemiology, 55(9), 893–899.
Utah Department of Health. (2005). Utah health status update: Adjusting Utah’s state health ranking for age [PDF]. Retrieved from http://health.utah.gov.
Van Naarden Braun, K., Pettygrove, S., Daniels, J., Miller, L., Nicholas, J., Baio, J., et al. (2007). Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders–Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. Surveillance Summaries: Morbidity and Mortality Weekly Report, 56(1), 29–40.
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. JAMA. Journal of the American Medical Association, 289(1), 49–55.
This research was supported by Autism Speaks Grant #5955. We thank the Pedigree and Population Resource (funded by the Huntsman Cancer Foundation) for its role in the ongoing collection, maintenance, and support of the Utah Population Database (UPDB).
About this article
Cite this article
Bilder, D., Botts, E.L., Smith, K.R. et al. Excess Mortality and Causes of Death in Autism Spectrum Disorders: A Follow up of the 1980s Utah/UCLA Autism Epidemiologic Study. J Autism Dev Disord 43, 1196–1204 (2013). https://doi.org/10.1007/s10803-012-1664-z
- Autism spectrum disorders
- Causes of death
- Intellectual disability